US Patent Issued to University of Jeddah, King Abdulaziz University on April 29 for "2-(5-aminopyridin-2-yl)-N-benzylacetamides and use thereof in the treatment of acute myeloid leukemia" (Saudi Arabia, American Inventors)

Posted On: 2025-06-09

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,418, issued on April 29, was assigned to University of Jeddah (Jeddah, Saudi Arabia) and King Abdulaziz University (Jeddah, Saudi Arabia).

"2-(5-aminopyridin-2-yl)-N-benzylacetamides and use thereof in the treatment of acute myeloid leukemia" was invented by Roaa M. Alreemi (Jeddah, Saudi Arabia), Hind A. Alkhatabi (Jeddah, Saudi Arabia), Abdelsattar M. Omar (Jeddah, Saudi Arabia), Mohammed A. Baradwan (Jeddah, Saudi Arabia), Yosra A. Muhammad (Jeddah, Saudi Arabia), Peter Natesan Pushparaj (Jeddah, Saudi Arabia), Mohammad Basabrain (Jeddah, Saudi Arabia) and Moustafa E. El-Araby (Richmond, Va.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Three com...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

US Patent Issued to University of Jeddah, King Abdulaziz University on April 29 for "2-(5-aminopyridin-2-yl)-N-benzylacetamides and use thereof in the treatment of acute myeloid leukemia" (Saudi Arabia, American Inventors)